View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
Wim Hoste
  • Wim Hoste

Akzo Nobel Feedback 4Q results conference call

Below are the highlights from the conference call. We remind that Akzo's 4Q adjusted EBITDA increased by 3% and came in c. 2% below our forecast and c. 1% below consensus, with a better than expected result of Performance Coatings offset by a weaker result of Deco Paints. Net debt/EBITDA came in weaker than expected at 3x on the back of incidentals and higher than expected working capital. FY25 adj EBITDA guidance calls for at least 5% growth which is in line with our forecast with consensus at ...

Jan Frederik Slijkerman ... (+5)
  • Jan Frederik Slijkerman
  • Jeroen van den Broek
  • Jesse Norcross
  • Nadège Tillier
  • Timothy Rahill
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AkzoNobel: 4Q24 misses on Adj. EBIT and FCF, 2025F guidance merely in-line. Alfen: Preview: Setting the stage? Arcadis: Work on PFAS. ASML: 4Q24 results – Building credit. Events Calendar

Alvaro del Pozo
  • Alvaro del Pozo

ASML HOLDING NV: RDOS. 4T’24 (ANÁLISIS BANCO SABADELL)

Rdos. 4T'24 vs 4T'23: Ventas: 9.263 M euros (+28,0% vs +24,0% BS(e) y +24,8% consenso); EBIT: 3.355 M euros (+40,3% vs +27,6% BS(e) y +28,6% consenso); BDI: 2.693 M euros (+31,5% vs +27,3% BS(e) y +28,2% consenso). Rdos. 2024 vs 2023: Ventas: 28.263 M euros (+2,6% vs +1,5% BS(e) y +1,7% consenso); EBIT: 9.022 M euros (-0,2% vs -3,6% BS(e) y -3,3% consenso); BDI: 7.572 M euros (-3,4% vs -4,5% BS(e) y -4,3% consenso).

Stefano Toffano
  • Stefano Toffano
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri
Guy Sips ... (+5)
  • Guy Sips
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
Wim Hoste
  • Wim Hoste

Akzo Nobel FIRST LOOK: 4Q EBITDA +3%, guiding for >5% growth on self-h...

Akzo's 4Q adjusted EBITDA increased by 3% and came in c. 2% below our forecast and c. 1% below consensus, with a better than expected result of Performance Coatings offset by a weaker result of Deco Paints. FY25 adj EBITDA guidance calls for at least 5% growth which is in line with our forecast with consensus at +7%, whilst most of the predicted growth comes from self-help measures. Taking into account the volatile track record and low structural growth, we maintain our Hold rating and € 70 TP.

Thibault Leneeuw
  • Thibault Leneeuw

ASML Higher IBM sales, lower costs, strong order intake

ASML's 4Q24 results exceed expectations. Order intake was € 7.1bn, twice the street's expectations of € 3.5bn. ASML reported €9.3bn in revenues for 4Q24, surpassing both guidance and expectations (KBCS & CSS: € 9.0bn) due to a strong performance of IBM. Higher IBM revenues combined with lower than expected costs, related to the sale of two high NA tools, resulted in better than expected margins. Consequently, EPS of € 6.85 exceeded the street's expectations of € 6.68 (KBCS: € 6.61). The outlook ...

Thomas Vranken
  • Thomas Vranken

Onward Medical FIRST LOOK: ARC-EX becomes available on VA procurement ...

Onward's ARC-EX system is now available on two federal procurement platforms, including the US Veterans Affairs (VA) and General Services Administration (GSA) Advantage, allowing US government clinics to purchase the system. The inclusion was facilitated by Onward's existing partnership with Lovell. The company remains on track in its commercial launch for the ARC-EX device, hence we reiterate our € 10.4 TP and Buy rating.

Pierre FerraguÊ
  • Pierre FerraguÊ

ASML 4Q24 QT: Strong rebound in orders, but downside risk persists fo...

ASML reported 4Q24 this morning. Please click below for our quick take on the print.

Research Department
  • Research Department

INFORME DIARIO 29 ENERO + RDOS. ESPAÑA Y EUROPA 4T’24. PREVIEWS (ANÁLI...

COMPAÑÍAS QUE APARECEN EN EL INFORME: EUROPA: ASML, LVMH. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. Recuperación del mercado Rebote en Europa ayudado por la recuperación de las grandes empresas estadounidenses (las FANGS subían un +5,1% al cierre de Europa). En el STOXX 600 lideraron...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch